This suggestion is consistent with our earlier reported correlation between loss of ER DNA-binding in ER-positive/PR-negative breast cancers [20], and with the present observation that numeric Ox-E/ER index values correlate inversely with PR transcript levels and tumor PR status. The gene discussed is ESR1; the disease is breast cancer.